Cargando…

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients

BACKGROUND: Myocardial infarction is the main mortality cause in patients with type 2 diabetes (T2DM). Endothelial dysfunction due to reduced bioavailability of nitric oxide (NO) is an early step of atherogenesis. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthesis, and it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannino, Gaia Chiara, Pezzilli, Serena, Averta, Carolina, Fuoco, Anastasia, Spiga, Rosangela, Mancuso, Elettra, Di Fatta, Concetta, Perticone, Francesco, Prudente, Sabrina, Trischitta, Vincenzo, Andreozzi, Francesco, Sesti, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693196/ https://www.ncbi.nlm.nih.gov/pubmed/31409409 http://dx.doi.org/10.1186/s12933-019-0906-1

Ejemplares similares

The polymorphism rs35767 at IGF1 locus is associated with serum urate levels
por: Mannino, Gaia C., et al.
Publicado: (2018)

Insulin-like growth factor-1 is a negative modulator of glucagon secretion
por: Mancuso, Elettra, et al.
Publicado: (2017)

A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity
por: Andreozzi, Francesco, et al.
Publicado: (2012)

Are Circulating Mg(2+) Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes?
por: Spiga, Rosangela, et al.
Publicado: (2019)

Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals
por: Andreozzi, Francesco, et al.
Publicado: (2017)

Association between Serum Mg(2+) Concentrations and Cardiovascular Organ Damage in a Cohort of Adult Subjects
por: Mancuso, Elettra, et al.
Publicado: (2020)

The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals
por: Mannino, Gaia Chiara, et al.
Publicado: (2021)

The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness
por: Averta, Carolina, et al.
Publicado: (2022)

A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase
por: Ragavan, Vinitha N., et al.
Publicado: (2023)

Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma
por: Shiozawa, Toshihiro, et al.
Publicado: (2015)

Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System
por: Kozlova, Alena A., et al.
Publicado: (2021)

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis
por: Kostourou, V, et al.
Publicado: (2002)

Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity
por: D'Mello, Richard, et al.
Publicado: (2015)

Regulation of dimethylarginine dimethylaminohydrolase 2 expression by NF-κB acetylation
por: Li, Jiaqi, et al.
Publicado: (2021)

Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis
por: Lange, Clemens, et al.
Publicado: (2016)

Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke
por: Leypoldt, Frank, et al.
Publicado: (2009)

Ligand-Dependent Dynamics of the Active-Site Lid in Bacterial Dimethylarginine Dimethylaminohydrolase
por: Rasheed, Masooma, et al.
Publicado: (2014)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
por: Murphy, Rhys B., et al.
Publicado: (2016)

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
por: Xie, Ziang, et al.
Publicado: (2022)

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
por: Mannino, Gaia Chiara, et al.
Publicado: (2019)

Asymmetric Dimethylarginine Plasma Levels and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients
por: Sciacqua, Angela, et al.
Publicado: (2012)

The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study
por: Lu, Tse-Min, et al.
Publicado: (2011)

A polymorphism at IGF1 locus is associated with anemia
por: Marini, Maria Adelaide, et al.
Publicado: (2017)

Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
por: Xuan, Chao, et al.
Publicado: (2016)

Overexpression of Dimethylarginine Dimethylaminohydrolase 1 Attenuates Airway Inflammation in a Mouse Model of Asthma
por: Kinker, Kayla G., et al.
Publicado: (2014)

Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: Tommasi, S., et al.
Publicado: (2017)

Exploring the role of dimethylarginine dimethylaminohydrolase-mediated reduction in tissue asymmetrical dimethylarginine levels in cardio-protective mechanism of ischaemic postconditioning in rats
por: Kaur, Kamaldeep, et al.
Publicado: (2019)

A Fasting Insulin–Raising Allele at IGF1 Locus Is Associated with Circulating Levels of IGF-1 and Insulin Sensitivity
por: Mannino, Gaia Chiara, et al.
Publicado: (2013)

Cerebral Changes Occurring in Arginase and Dimethylarginine Dimethylaminohydrolase (DDAH) in a Rat Model of Sleeping Sickness
por: Amrouni, Donia, et al.
Publicado: (2011)

Chemical Compounds and Ambient Factors Affecting Pancreatic Alpha-Cells Mass and Function: What Evidence?
por: Mannino, Gaia Chiara, et al.
Publicado: (2022)

Dimethylarginine Dimethylaminohydrolase1 Is an Organ-Specific Mediator of End Organ Damage in a Murine Model of Hypertension
por: Sydow, Karsten, et al.
Publicado: (2012)

A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1
por: Buijs, Nikki, et al.
Publicado: (2017)

Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer
por: Hulin, Julie-Ann, et al.
Publicado: (2020)

Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: Essential roles of dimethylarginine dimethylaminohydrolase-1
por: Wang, Ying, et al.
Publicado: (2021)

Dimethylarginine dimethylaminohydrolase 1 protects PM(2.5) exposure-induced lung injury in mice by repressing inflammation and oxidative stress
por: Gao, Junling, et al.
Publicado: (2022)

The Triglycerides and Glucose (TyG) Index Is Associated with 1-Hour Glucose Levels during an OGTT
por: Massimino, Mattia, et al.
Publicado: (2022)

Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis
por: Park, K, et al.
Publicado: (2009)

Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis
por: Chertow, Jessica H., et al.
Publicado: (2015)

MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
por: Hulin, Julie-Ann, et al.
Publicado: (2017)

Oxidative Stress and Left Ventricular Performance in Patients with Different Glycometabolic Phenotypes
por: Cassano, Velia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nq9p63s5c2c3mq4uied50hgnd8